跳至主要内容
临床试验/ACTRN12620000776909
ACTRN12620000776909已完成未知

PROtein dose and Muscle Synthesis in critically ill patients (PROMS)

Royal Adelaide Hospital0 个研究点目标入组 20 人开始时间: 2020年7月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • *Adults (18 years of age and above)
  • *Admitted to the intensive care unit at the Royal Adelaide Hospital
  • *Mechanically ventilated and expected to remain ventilated until the day after recruitment
  • *Suitable for enteral feeding
  • *Arterial line in situ

排除标准

  • Exclusions:
  • *Recent upper abdominal surgery
  • *Lactose intolerance
  • *Any order to withhold active treatment
  • *Jehovah’s Witness
  • *Pregnancy
  • *Receiving dialysis
  • *For muscle biopsy: Bleeding diathesis (INR > 2; APTT > 50, platelets < 50) including those receiving anticoagulants (other than low dose for DVT prophylaxis) and anti-platelet agents

研究者

相似试验

PROtein dose and Muscle Synthesis in critically ill... | 临床试验